| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/04/2002 | CN1367700A Small peptides and method for downregulation of lgE |
| 09/04/2002 | CN1367697A Therapeutical method for improving cognition |
| 09/04/2002 | CN1367695A Phthalazine derivatives for treating inflammatory diseases |
| 09/04/2002 | CN1367694A Camptothecin analogs and methods of preparation thereof |
| 09/04/2002 | CN1367693A Pharmaceutical compositions containing poly(ADP-ribose) glycohydrolase inhibitors and method of using the same |
| 09/04/2002 | CN1367689A Utilisation of inhibitors of sodium hydrogen exchanger for producing medicament for preventing organ dysfunctions and diseases related to particular age and for prolonging life |
| 09/04/2002 | CN1367688A Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to graft |
| 09/04/2002 | CN1367169A Substituted 6,6-Hetero-dicycloderivative |
| 09/04/2002 | CN1367029A Therapeutic patch |
| 09/04/2002 | CN1366982A Chinese medicine Tongshuyin for curing cardiopathy, biliary disease and kidney disease |
| 09/04/2002 | CN1366973A Nano Guishe preparation medicine and preparation method |
| 09/04/2002 | CN1366972A Nano Guogong preparation medicine and preparation method |
| 09/04/2002 | CN1366967A Nano Biwen preparation medicine and preparation method |
| 09/04/2002 | CN1366947A Nano Fufang Qianzheng preparation medicine and preparation method |
| 09/04/2002 | CN1366925A Nano stomach-clearing coptis preparation medicine and preparation method |
| 09/04/2002 | CN1366918A Nano navel-warming preparation medicine and preparation method |
| 09/04/2002 | CN1366911A Nano Naolejing preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366888A Nano quicken the blood and disperse welling abscess preparation medicine and preparation method thereof |
| 09/04/2002 | CN1366883A Chitin lozenge and its preparation method |
| 09/04/2002 | CN1366881A Method for curing some cancers by using estrogenic excitomotor and agonist |
| 09/04/2002 | CN1366874A Personal nursing compound |
| 09/04/2002 | CN1090190C Heterocycle-condensed morphinoid derivatives and its preparing method and use |
| 09/04/2002 | CN1090189C Pyrazolopyrimidines type compound |
| 09/04/2002 | CN1090188C Benzonaphthyrindines compound |
| 09/04/2002 | CN1090024C Method for preparation of medicine capable of improving sexual function, enhancing immunity and removing fatigue |
| 09/04/2002 | CN1090023C Method for production of solid tea fungus active medicinal preparation |
| 09/04/2002 | CN1090020C 4,4-(disubstituted) cyclohexan-1-ols and related compounds |
| 09/04/2002 | CN1090019C 组合物 The composition |
| 09/03/2002 | US6444811 Central nervous system disorders; cardiovascular disorders |
| 09/03/2002 | US6444809 Antihistamines |
| 09/03/2002 | US6444803 Bone mineralization proteins, DNA, vectors, expression systems |
| 09/03/2002 | US6444793 Hydrophobically-modified hedgehog protein compositions and methods |
| 09/03/2002 | US6444790 Peptidoglycan recognition proteins |
| 09/03/2002 | US6444701 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 09/03/2002 | US6444696 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
| 09/03/2002 | US6444694 Styryl benzimidazole derivatives |
| 09/03/2002 | US6444691 1,3-disubstituted ureas as ACAT inhibitors, and method of preparing thereof |
| 09/03/2002 | US6444688 Compounds and compositions with nitrogen-containing non-basic side chains |
| 09/03/2002 | US6444679 Neurological and gastrointestinal disorders; delta opioid ligands or opioid receptors |
| 09/03/2002 | US6444677 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 09/03/2002 | US6444657 2-(phosphonomethyl)pentanedioic acid; 2-(2-sulfanylethyl) pentanedioic acid; epithelial tissue scarring, collagen vascular disease, fibroproliferation, connective tissue disorder, respiratory distress syndrome; tgf regulator |
| 09/03/2002 | US6444655 Galactopyranosides and their use |
| 09/03/2002 | US6444646 Use of angiotensin II type 2 receptor agonists in tissue repair |
| 09/03/2002 | US6444644 Peptide having specified amino acid sequence; used for inhibition of thromboplastin |
| 09/03/2002 | US6444642 Administering to mammal effective amount of neuregulin polypeptide with p185.sup.erbb2 protein binding activity to stimulate myogenesis of muscle cells |
| 09/03/2002 | US6444434 Compounds inhibiting the activation of fx to fxa by tf/fviia. the compounds are anticoagulants. the invention also relates to a method of identifying a drug candidate. |
| 09/03/2002 | US6444431 Angiostatin receptor |
| 09/03/2002 | US6444233 Triterpene compositions and methods for use thereof |
| 09/03/2002 | US6444206 Sepsis therapy; monoclonal antibodies |
| 09/03/2002 | CA2237189C 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 09/03/2002 | CA2178085C Glutaramide derivatives |
| 09/03/2002 | CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 09/01/2002 | CA2373578A1 .beta.3, agonists and uses thereof |
| 08/29/2002 | WO2002066681A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 08/29/2002 | WO2002066647A2 Type 2 ctokine receptor and nucleic acids encoding same |
| 08/29/2002 | WO2002066640A2 Zinc finger binding domains for nucleotide sequence ann |
| 08/29/2002 | WO2002066516A2 Antibodies that bind both bcma and taci |
| 08/29/2002 | WO2002066514A2 Artificial fusion proteins with reduced immunogenicity |
| 08/29/2002 | WO2002066480A2 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
| 08/29/2002 | WO2002066479A1 Novel isoindole derivatives |
| 08/29/2002 | WO2002066473A1 8’4-’3-(5-fluoro-1h-indol-3yl) propyl!-1-piperazynyl!-2-methyl-2h-1,4-benzoxazin -3 (4h)- one methanesulfonate with high affinity for the dopamine d 2 receptor and the serotonin reuptake site |
| 08/29/2002 | WO2002066472A1 New phenylpiperazines |
| 08/29/2002 | WO2002066470A1 Substituted alkylamine derivatives and methods of use |
| 08/29/2002 | WO2002066469A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066468A2 Heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066462A1 Pyrazole derivatives against tgf overexpression |
| 08/29/2002 | WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/29/2002 | WO2002066458A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
| 08/29/2002 | WO2002066456A2 Thiophene substituted amine derivatives as glyt-1 inhibitors |
| 08/29/2002 | WO2002066450A2 Anthrone derivatives and their use as ink inhibitors |
| 08/29/2002 | WO2002066445A1 Quinazoline derivatives |
| 08/29/2002 | WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 08/29/2002 | WO2002066430A1 Tryptase inhibitors |
| 08/29/2002 | WO2002066429A1 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby |
| 08/29/2002 | WO2002066426A2 Fluoro oxindole derivatives as modulators of kcnq potassium channels |
| 08/29/2002 | WO2002066422A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 08/29/2002 | WO2002066421A1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects |
| 08/29/2002 | WO2002066420A2 Tryptase inhibitors |
| 08/29/2002 | WO2002066068A2 Method of treating neurological diseases |
| 08/29/2002 | WO2002066063A1 Remedies for metabolic bone diseases |
| 08/29/2002 | WO2002066061A1 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 08/29/2002 | WO2002066058A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | WO2002066056A2 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 08/29/2002 | WO2002066050A1 Casoase 3 inhibitors |
| 08/29/2002 | WO2002066049A1 Agents for plasmic change |
| 08/29/2002 | WO2002066044A2 Method for dendritic cells based immunotherapy of tumors using combination therapy |
| 08/29/2002 | WO2002066036A1 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators |
| 08/29/2002 | WO2002066035A2 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/29/2002 | WO2002066034A1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 08/29/2002 | WO2002066033A1 Epothilone derivatives for the treatment of refractory tumors |
| 08/29/2002 | WO2002066030A1 Medicinal compositions comprising diclofenac and ornoprostil |
| 08/29/2002 | WO2002065989A2 Aminoglycoside treatment for lysosomal storage diseases |
| 08/29/2002 | WO2002065988A2 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/29/2002 | WO2002065986A2 Transporters comprising spaced arginine moieties |
| 08/29/2002 | WO2002065979A2 (diazolo-pyridinyl)-pyrimidines for use in treatment of cns disorders and diabetes |
| 08/29/2002 | WO2002065943A2 Ocular tear growth factor-like protein |
| 08/29/2002 | WO2002047668A3 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 08/29/2002 | WO2002042273A3 Acid derivatives useful as serine protease inhibitors |
| 08/29/2002 | WO2002034286B1 Methods for treating endocrine disorders |
| 08/29/2002 | WO2002034233A3 Use of an association of a carotenoid and of an isoflavonoid for treating cutaneous symptoms of ageing |